Molecular docking analysis on the designed benzimidazole derivatives as EGFR inhibitors: comparison between EGFR wild-type (EGFRWT) and T790M mutant
The non-small cell lung (NSCL) and colorectal cancers are frequently linked with the oncogenic activation of the epidermal growth factor receptor (EGFR), a member of the receptor tyrosine kinase (RTK) family. Current tyrosine kinase inhibitors (TKIs) are susceptible to drug resistance mutations and...
| Main Authors: | Nurul Awani Syazzira Jalil, Shafida Abd Hamid |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universiti Kebangsaan Malaysia
2023
|
| Online Access: | http://journalarticle.ukm.my/22069/ http://journalarticle.ukm.my/22069/1/SE%2013.pdf |
Similar Items
Small Cell Transformation and T790M Mutation as
Coresistance Mechanisms for First-line Epidermal
Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy Failure
by: Chee, Shee Chai
Published: (2017)
by: Chee, Shee Chai
Published: (2017)
EGFR-directed tyrosine kinase inhibitors for non-small cell lung cancer
by: Fatin Nur Elyana Mohd Sidek,, et al.
Published: (2025)
by: Fatin Nur Elyana Mohd Sidek,, et al.
Published: (2025)
Development of an EGFR-targeted Drug Delivery System for Glioblastoma
by: Zhao, Zi-Ruo
Published: (2023)
by: Zhao, Zi-Ruo
Published: (2023)
Dynamics of ligand and nanobody binding at CXCR4/EGFR complexes
by: Comez, Dehan
Published: (2025)
by: Comez, Dehan
Published: (2025)
Characteristics of epidermal growth factor receptor (EGFR)-Mutated Non Small Cell Lung Carcinoma (NSCLC)-patients who developed resistance to first or second generation Egfrtyrosine Kinase Inhibitor (TKI) Therapy through T790M mutation / Vijayan Munusamy
by: Vijayan, Munusamy
Published: (2017)
by: Vijayan, Munusamy
Published: (2017)
Cytotoxicity, antimutagenicity and molecular docking of benzimidazole derivatives as anticancer agents
by: Azahar, Nurul Hafizan
Published: (2021)
by: Azahar, Nurul Hafizan
Published: (2021)
Computer-aided anti-cancer drug discovery of EGFR protein based on virtual screening of drug bank, ADMET, docking, DFT and molecular dynamic simulation studies
by: Roney, Miah, et al.
Published: (2023)
by: Roney, Miah, et al.
Published: (2023)
Study On The Involvement Of Wif-1 In
Oral Carcinogenesis Via Egfr And Wnt
Signaling Pathways
by: Chow , Tan Wei
Published: (2015)
by: Chow , Tan Wei
Published: (2015)
Upregulation and hypomethylation of EGFR in Formalin-fixed Paraffin Embedded FFPE tissues of colon adenocarcinoma
by: Othman, Rosfayati, et al.
Published: (2021)
by: Othman, Rosfayati, et al.
Published: (2021)
Identification of potent new brain cancer EGFR inhibitor from usimine A and usimine B: computer-aided drug design perspective
by: Roney, Miah, et al.
Published: (2024)
by: Roney, Miah, et al.
Published: (2024)
Synthesis and molecular docking of carvone derivatives as a potential neuraminidase inhibitors
by: Jusoh, Noorakmar, et al.
Published: (2016)
by: Jusoh, Noorakmar, et al.
Published: (2016)
Detecting intratumoral heterogeneity of EGFR activity by liposome-based in vivo transfection of a fluorescent biosensor
by: Weitsman, Gregory, et al.
Published: (2017)
by: Weitsman, Gregory, et al.
Published: (2017)
LRG1 promotes metastatic dissemination of melanoma through regulating EGFR/STAT3 signalling
by: Kwan, Yuet Ping, et al.
Published: (2021)
by: Kwan, Yuet Ping, et al.
Published: (2021)
Overcoming resistance of targeted EGFR monotherapy by inhibition of STAT3 escape pathway in soft tissue sarcoma
by: Wang, X., et al.
Published: (2016)
by: Wang, X., et al.
Published: (2016)
Interactions of the EGFR juxtamembrane domain with PIP2-containing lipid bilayers: insights from multiscale molecular dynamics simulations
by: Abd Halim, Khairul Bariyyah, et al.
Published: (2015)
by: Abd Halim, Khairul Bariyyah, et al.
Published: (2015)
Expression of BRAF, EGFR and CD10 in ameloblastoma: Their potential role in local tumour invasiveness / Tan Chuey Chuan
by: Tan, Chuey Chuan
Published: (2017)
by: Tan, Chuey Chuan
Published: (2017)
Comparison And Assessment Of Methods Used To Estimate Egfr In Ckd Patients: The Role Of Clinical Pharmacist And Direct Medical Costs
by: Abdulla, Aljasmi Saba Mohsen Mohamed
Published: (2021)
by: Abdulla, Aljasmi Saba Mohsen Mohamed
Published: (2021)
Effects of small molecule inhibitors targeting PI3K, EGFR, IGF-1R, MTOR, SMAD3 and MEK in tube formation and 3-D spheroid assay
by: Ng, Chin Tat
Published: (2014)
by: Ng, Chin Tat
Published: (2014)
Synthesis, characterization and anti-proliferation study of some Benzimidazole derivatives
by: Al-Douh, Mohammed H., et al.
Published: (2011)
by: Al-Douh, Mohammed H., et al.
Published: (2011)
Synthesis, neuraminidase inhibition assay and molecular docking of carvone derivatives
by: Abd Hamid, Shafida
Published: (2019)
by: Abd Hamid, Shafida
Published: (2019)
Epidermal growth factor receptor (EGFR) mutations are the main oncogenic driver mutation in adenocarcinoma in never-smokers - findings from the emlan study
by: Liam, Chong Kin, et al.
Published: (2012)
by: Liam, Chong Kin, et al.
Published: (2012)
Structure elucidation and docking analysis of 5M mutant of T1 lipase Geobacillus zalihae
by: Ishak, Siti Nor Hasmah, et al.
Published: (2021)
by: Ishak, Siti Nor Hasmah, et al.
Published: (2021)
Huge relief for 790 varsity students
by: Rajaendram, Rebecca, et al.
Published: (2020)
by: Rajaendram, Rebecca, et al.
Published: (2020)
Sulfated galactans from red seaweed Gracilaria fisheri target epidermal growth factor receptor (EGFR) and inhibit cholangiocarcinoma cells (CCA) proliferation
by: Sae-lao, Thannich, et al.
Published: (2017)
by: Sae-lao, Thannich, et al.
Published: (2017)
Synthesis of thymidine phosphorylase inhibitor based on quinoxaline derivatives and their molecular docking study
by: Noor Barak, Almandil, et al.
Published: (2019)
by: Noor Barak, Almandil, et al.
Published: (2019)
Synthesis of thymidine phosphorylase inhibitor based on quinoxaline derivatives and their molecular docking study
by: Almandil, Noor Barak, et al.
Published: (2019)
by: Almandil, Noor Barak, et al.
Published: (2019)
Synthesis And Biological Activity Of Benzimidazole Analogs As Sirtuin Enzyme Inhibitors
by: Yeong, Keng Yoon
Published: (2016)
by: Yeong, Keng Yoon
Published: (2016)
Around 790 IPT students return home
by: Birruntha, S.
Published: (2020)
by: Birruntha, S.
Published: (2020)
Synthesis, characterization and molecular docking of hydroxyxanthone and renylated xanthone derivatives as potential aromatase inhibitor
by: Ramakrishnan, Shurutishria
Published: (2022)
by: Ramakrishnan, Shurutishria
Published: (2022)
Effects of disrupting insulin-like growth factor-1 receptor (IGF-1R) signal transduction pathways with inhibitors of IGF-1R, EGFR, PI3K, MEK, and MTOR in breast cancer cell lines
by: Ayub, Ayunadirah
Published: (2014)
by: Ayub, Ayunadirah
Published: (2014)
Benzimidazole derivatives as potential dual inhibitors for poly (adp-ribose) polymerase-1 and dihydroorotate
dehydrogenase / Iskandar Abdullah
by: Iskandar, Abdullah
Published: (2015)
by: Iskandar, Abdullah
Published: (2015)
Evaluation of potential bacterial protease inhibitor properties of selected hydroxyquinoline derivatives : An in silico docking and molecular dynamics simulation approach
by: Riaz, Faiza, et al.
Published: (2023)
by: Riaz, Faiza, et al.
Published: (2023)
Design and synthesis of benzimidazole-based Rho kinase inhibitors for the treatment of glaucoma
by: Abbhi, V., et al.
Published: (2017)
by: Abbhi, V., et al.
Published: (2017)
Detection of Isocitrate Dehydrogenase (IDH-1), Epidermal Growth Factor Receptor (EGFR), P53 and C-erbB2/HER2 mutation in glial tumour
by: Azman, Nusaibah, et al.
Published: (2022)
by: Azman, Nusaibah, et al.
Published: (2022)
Antituberculosis: Synthesis and Antimycobacterial Activity of Novel Benzimidazole Derivatives
by: Yeong, Keng Yoon, et al.
Published: (2013)
by: Yeong, Keng Yoon, et al.
Published: (2013)
Synthesis of new isoquinoline-base-oxadiazole derivatives as potent inhibitors of thymidine phosphorylase and molecular docking study
by: Zaman, Khalid, et al.
Published: (2019)
by: Zaman, Khalid, et al.
Published: (2019)
Computational quest for finding potential Ebola VP40 inhibitors: a molecular docking study
by: Mohamad Ariff Mohamad Yussoff,, et al.
Published: (2020)
by: Mohamad Ariff Mohamad Yussoff,, et al.
Published: (2020)
Pharmacokinetics And Metabolism Studies
Of Antifilarial Drugs
Derivatives Of Benzimidazole Carbamate
by: Ramanathan, Surash
Published: (1996)
by: Ramanathan, Surash
Published: (1996)
Synthesis, Characterization And Anti-Proliferation Study Of Some Benzimidazole Derivatives
by: al-Douh, Mohammed Hadi Saeed
Published: (2010)
by: al-Douh, Mohammed Hadi Saeed
Published: (2010)
A quest on finding new potential ebola vp40 inhibitors: molecular docking and molecular dynamics simulation studies
by: Mohamad Yussoff, Mohamad Ariff, et al.
Published: (2018)
by: Mohamad Yussoff, Mohamad Ariff, et al.
Published: (2018)
Similar Items
-
Small Cell Transformation and T790M Mutation as
Coresistance Mechanisms for First-line Epidermal
Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy Failure
by: Chee, Shee Chai
Published: (2017) -
EGFR-directed tyrosine kinase inhibitors for non-small cell lung cancer
by: Fatin Nur Elyana Mohd Sidek,, et al.
Published: (2025) -
Development of an EGFR-targeted Drug Delivery System for Glioblastoma
by: Zhao, Zi-Ruo
Published: (2023) -
Dynamics of ligand and nanobody binding at CXCR4/EGFR complexes
by: Comez, Dehan
Published: (2025) -
Characteristics of epidermal growth factor receptor (EGFR)-Mutated Non Small Cell Lung Carcinoma (NSCLC)-patients who developed resistance to first or second generation Egfrtyrosine Kinase Inhibitor (TKI) Therapy through T790M mutation / Vijayan Munusamy
by: Vijayan, Munusamy
Published: (2017)